World Tuberculosis Day: Treating the untreatable

With 84,000 cases of drug-resistant tuberculosis, India has the highest burden of DR-TB in the world. In Mumbai, MSF has been providing not just medical treatment but holistic care to people living with DR-TB. Watch this video to find out more.

Jharkhand: What motherhood taught me about malnutrition

Name : Designation : Subashini is from Jharkhand, where she works with MSF as a Community Health Educator to improve local communities’ understanding of health and nutrition. But it was her own experience as a young mother with a malnourished child that inspired her to help others avoid the same story. In this animated video … Read more

Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India

Mumbai/Cape Town – Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita Venkatesan from Mumbai, India and Phumeza Tisile from Khayelitsha, South Africa, who filed the patent … Read more

Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India

Mumbai/Cape Town – Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita Venkatesan from Mumbai, India and Phumeza Tisile from Khayelitsha, South Africa, who filed the … Read more

Video: Explaining kala azar-HIV coinfection

Kala azar or visceral leishmaniasis a neglected tropical disease and the second-largest parasitic killer in the world. India accounts for over 30% of the total kala azar cases in the world. 80% of these cases occur in Bihar. Since 2007, MSF is providing treatment for kala azar in Bihar. While there has been a sharp … Read more

Bihar: On the frontline of treating kala azar-HIV co-infection

Kala azar is one of the most dangerous neglected tropical diseases in the world. It is spread to humans by bites from infected female sand flies and attacks the immune system. While cases of the disease are declining steadily, kala azar-HIV co-infection is fast becoming a serious threat. After treating over 12,000 kala azar patients … Read more

Bihar: "I try to bring hope to patients living with kala azar-HIV co-infection"

Name : Designation : Interview conducted and written by Kavitha Devadas for MSF Kala azar is one of the most dangerous neglected tropical diseases in the world. It is spread to humans by bites from infected female sand flies and attacks the immune system. While cases of the disease are declining steadily, kala azar-HIV co-infection … Read more

National Doctors’ Day: “Treating the most vulnerable in the most critical situations”

Name : Designation : 1 July is observed in India as National Doctors’ Day. To mark the occasion we asked three MSFers how they became doctors, and what it means to be a doctor without borders.     Shazeer Majeed  As a kid, I grew up listening to people say I had to be a doctor … Read more

MSF’s hepatitis C project in Uttar Pradesh: One year, 1,198 patients

In January 2017, Doctors Without Borders/Médecins Sans Frontiéres (MSF), in collaboration with the National Health Mission in Uttar Pradesh, started a pilot hepatitis project in Meerut city. Uttar Pradesh is one of the largest Indian states and has an estimated population of more than 200 million people. The free clinic, located at the PL Sharma … Read more

Uttar Pradesh: "Hepatitis C is more than a disease"

Name : Designation : Sevantee Ghosh, a medical doctor from Kolkata, has been working with MSF’s hepatitis C project in Meerut, Uttar Pradesh, since January 2017. In this piece, she looks back on a year of treating hepatitis C. I have been working at the clinic in Meerut from the day it opened.  The assessment … Read more